WASHINGTON -- Many of the world's richest countries have spent the past year hoarding coronavirus vaccines, buying up enough doses to vaccinate their populations several times over and consistently ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
NEWARK, Calif. (KGO) -- The race is underway to produce and use the omicron variant's DNA to determine how well existing vaccines work against it, ahead of the first case surfacing in the U.S. The Bay ...
NEW YORK (WABC) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus ...
The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...
Moderna says it has developed a COVID-19 booster intended to create a more robust immune response against the omicron variant than its previous vaccine. The company said it has provided information to ...
New guidance backs seasonal COVID-19 vaccination in immunocompromised patients. Read more on timing and risk groups.
Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results